Conceivable Life Sciences

Conceivable Life Sciences is a New York-based reproductive-medicine company building AURA, described as the world's first AI-powered, automation-assisted IVF laboratory. Using robotics, machine vision, advanced optics and proprietary software, AURA standardizes the 200-plus intricate microscopic steps of in vitro fertilization - from sperm and egg preparation through robotic ICSI, embryo culture and vitrification - to reduce human variability, lower cost, and widen access to fertility care. Founded in 2022 by Joshua Abram, Alan Murray and Dr. Alejandro Chavez-Badiola, the company reported the first live birth from a digitally controlled, remotely operated ICSI system and raised a $50M Series A in 2025 to bring its lab to the U.S.